CRSP Sep 2024 115.000 call
| Previous close | 3.1500 |
| Open | 3.4000 |
| Bid | 0.4000 |
| Ask | 0.5000 |
| Strike | 115.00 |
| Expiry date | 2024-09-20 |
| Day's range | 3.1500 - 3.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 162 |
GlobeNewswireCRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024. Dr. Patel is an experienced drug developer who has worked across a wid
Insider Monkey15 Best ARK Stocks To Buy Now
In this article, we will take a look at the 15 best ARK stocks to buy now. To see more such companies, go directly to 5 Best ARK Stocks To Buy Now. Cathie Wood is one of the most polarizing, and prominent figures on Wall Street. With over three decades of experience in the financial sector, […]
ZacksInvestors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
